Needle precision: ultrasound-guided shot eases stubborn knee pain
NCT ID NCT04943341
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested an ultrasound-guided injection of triamcinolone (a steroid) mixed with lidocaine (a numbing agent) directly into the knee's medial plica fold. The goal was to see if this targeted approach could reduce pain and improve function in 30 people with medial plica syndrome who hadn't improved with standard treatments. Researchers tracked outcomes using pain scales and knee function scores, along with safety monitoring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Triamcinolone Acetonide (Kenacort) with Lidocaine
- What this could lead to
- If it works, this could offer a targeted, non-surgical option for persistent knee pain from medial plica syndrome.
- What could go wrong
- This is a small pilot study with only 30 people, so results may not apply widely. The injection is a steroid, which can have side effects like tissue damage or infection, though rare.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIAL PLICA SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istituto Ortopedico Rizzoli
Bologna, 40136, Italy